Search research articles
Contact Us
Filters
Showing results (91-100 of 178) with videos related to
Page
of 18
Sort By:
Parkinsonism & Related Disorders
|
September 14, 2020
Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes
Jennifer S Hui, Susan H Fox, William Neeson, et al.
Movement Disorders Clinical Practice
|
February 5, 2019
Learning More from Finger Tapping in Parkinson's Disease: Up and Down from Dyskinesia to Bradykinesia
Marina Picillo, Gustavo B Vincos, Drew S Kern, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2012
L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
Philippe Huot, Tom H Johnston, James B Koprich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2010
Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation
Pettarusp M Wadia, Gamaliel Tan, Renato P Munhoz, et al.
Archives of Neurology
|
September 13, 2006
Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease
Susan H Fox, Naomi P Visanji, Tom H Johnston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 4, 2016
Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia
Renato P Munhoz, Marina Picillo, Susan H Fox, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 23, 2010
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease
Susan H Fox, Naomi Visanji, Gaby Reyes, et al.
The Lancet. Neurology
|
March 16, 2020
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M A de Bie, Carl E Clarke, Alberto J Espay, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 28, 2025
Reply: "Treatment Options for Motor Fluctuations in Parkinson's Disease"
Rob M A de Bie, Regina Katzenschlager, Veronica Bruno, et al.
The Lancet. Neurology
|
July 24, 2020
Initiating pharmacotherapy in early Parkinson's disease
Anthony E Lang, Rob M A de Bie, Carl E Clarke, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 178) with videos related to
Sort By:
Page
of 18
Parkinsonism & Related Disorders
|
September 14, 2020
Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes
Jennifer S Hui, Susan H Fox, William Neeson, et al.
Movement Disorders Clinical Practice
|
February 5, 2019
Learning More from Finger Tapping in Parkinson's Disease: Up and Down from Dyskinesia to Bradykinesia
Marina Picillo, Gustavo B Vincos, Drew S Kern, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2012
L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
Philippe Huot, Tom H Johnston, James B Koprich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 30, 2010
Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation
Pettarusp M Wadia, Gamaliel Tan, Renato P Munhoz, et al.
Archives of Neurology
|
September 13, 2006
Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease
Susan H Fox, Naomi P Visanji, Tom H Johnston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 4, 2016
Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia
Renato P Munhoz, Marina Picillo, Susan H Fox, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 23, 2010
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease
Susan H Fox, Naomi Visanji, Gaby Reyes, et al.
The Lancet. Neurology
|
March 16, 2020
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M A de Bie, Carl E Clarke, Alberto J Espay, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 28, 2025
Reply: "Treatment Options for Motor Fluctuations in Parkinson's Disease"
Rob M A de Bie, Regina Katzenschlager, Veronica Bruno, et al.
The Lancet. Neurology
|
July 24, 2020
Initiating pharmacotherapy in early Parkinson's disease
Anthony E Lang, Rob M A de Bie, Carl E Clarke, et al.
Page
of 18